FTV

Fortive Corp. Q3 2025 Filing Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended September 26, 2025. Fortive Corporation operates two strategic segments: Intelligent Operating Solutions (IOS) and Advanced Healthcare Solutions (AHS). A material event during this period was the completion of the separation of its former Precision Technologies segment into Ralliant Corporation on June 28, 2025. Consequently, Ralliant is reported as discontinued operations, and all financial data presented herein reflects continuing operations unless otherwise noted.

Key Financial Metrics

Note: Total Net Earnings includes a loss of $62.0 million from discontinued operations in Q3 2025, compared to earnings of $110.1 million in Q3 2024.

Material Changes vs. Prior Period

• Revenue Growth: Total sales increased 2.3% in Q3 and 0.9% YTD compared to 2024. Core revenue (excluding currency and acquisitions) grew 1.9% in Q3 and 1.1% YTD, driven by favorable pricing (2.6% in Q3) partially offset by volume declines (0.7% in Q3).
• Profitability: Operating profit margin decreased 160 basis points in Q3 to 15.5% (from 17.1% in Q3 2024). This decline was primarily due to incremental stock-based compensation costs related to the Ralliant separation ($33 million in Q3), higher employee compensation, and restructuring charges.
• Segment Performance:
  • IOS: Sales grew 2.6% in Q3; operating profit margin improved 110 basis points to 25.9%.
  • AHS: Sales grew 1.9% in Q3; operating profit margin improved 150 basis points to 12.9%.
• Balance Sheet: Total assets decreased significantly from $17.0 billion (Dec 2024) to $11.9 billion (Sep 2025) due to the removal of discontinued operations assets ($4.7 billion). Cash and equivalents declined from $813.3 million to $430.8 million.
• Debt Reduction: The company utilized proceeds from the Ralliant dividend ($1.15 billion) to repay approximately $716 million in debt, including Euro and Yen term loans and a portion of Euro-denominated notes.

Guidance, Outlook, and Risks

Management Commentary: Management highlighted that pricing actions and productivity gains via the Fortive Business System (FBS) helped offset volume declines and tariff impacts. The company continues to monitor geopolitical events, trade policies, and the impact of the Ralliant separation.

Capital Allocation:

• Share Repurchases: The company repurchased 20.8 million shares in Q3 2025 for approximately $1.0 billion. As of September 26, 2025, $78.2 million remains authorized under the Special Purpose Share Repurchase Program funded by Ralliant proceeds, and 8.3 million shares remain under the General Program.
• Dividends: A quarterly dividend of $0.06 per share was paid in Q3 2025.

Risks and Contingencies:

• Trade and Tariffs: Uncertainty regarding reciprocal tariffs implemented in August 2025, with some postponed until November 2025.
• Regulatory: Potential impacts from the "One Big Beautiful Bill Act" (H.R.1) and OECD Pillar Two global minimum tax rules.
• Separation Indemnities: Potential liabilities related to indemnification provisions in separation agreements with Ralliant and Vontier.

Investor Verification Checklist

• Discontinued Operations Impact: Verify the exclusion of Ralliant's financials from continuing operations and the specific costs ($46 million in Q3) recorded in discontinued operations.
• Stock-Based Compensation: Confirm the $33 million one-time expense in Q3 related to the separation and its impact on future quarters.
• Debt Structure: Review the remaining debt obligations, specifically the Euro-denominated notes and the utilization of the $2.0 billion revolving credit facility.
• Core Revenue Trends: Monitor the divergence between GAAP revenue growth and core revenue growth to assess the impact of currency fluctuations and pricing power.
• Share Count: Note the significant reduction in outstanding shares (from 341.2 million to 317.6 million) due to repurchases and the separation distribution.